Antidiabetic, Antihypertensive and Statin Medication Use in Metabolic Syndrome

International Journal of Pharmaceutical Sciences and Developmental Research
Research Article
Background: Metabolic syndrome (MetS) is characterised by a cluster of metabolic risk factors, which eventually increases the risk of diabetes and cardiovascular disease (CVD). The aim of the current study was to investigate medication use in outpatient communities with respect to the occurrence of these metabolic risk factors as defined by ATPIII.
http://www.peertechz.com/Pharmaceutical-Sciences-Developmental-Research/pdf/IJPSDR-1-105.pdf

Comments

Popular posts from this blog

Anterior Tarsal Tunnel Syndrome with Presence of Accessory Deep Peroneal Nerve: Case Report

Sarcoidosis-Lymphoma Syndrome presenting by severe Cholestatic Hepatitis